New Ambulatory Care Center Opens in Midtown Manhattan
NYU Langone Ambulatory Care Center East 41st Street, opening April 9, 2018, is one of NYU Langone’s largest ambulatory facilities.
New Anti-Aging Properties Found in Old Diabetes Drugs
NYU Langone researchers find that a type of medication used to increase insulin sensitivity can prevent or delay many age-related pathologies.
New Antibodies Show Potential Against Neurological Diseases
NYU Langone study finds experimental antibodies target a structural feature shared by proteins linked to several neurological conditions.
New Approach Enhances Patient Success in Managing Diabetes
Dr. Lauren H. Golden, at NYU Langone’s Center for Diabetes and Metabolic Health, focuses on enhancing patient success in diabetes management.
New Approach for Treating Childhood Leukemia
New research from NYU Langone suggests that targeting tumor cells’ microenvironment could lead to new treatments for childhood leukemia.
New Approach May Counter Autoimmunity
NYU Langone researchers found in a new study in mice that an engineered protein turns off the immune cells most likely to damage tissue in several conditions.
New Approach Promises to Revolutionize MRI Scanner Design
NYU Langone researchers harness imperfections that typically compromise MRI exams to achieve superior images.
New Approach to Treating Osteoarthritis Advances
NYU Langone study in rodents shows that injections of a natural “energy” molecule prompted regrowth of cartilage lost with aging in knees.
New Beta Thalassemia Treatment May Reduce Blood Transfusions
Dr. Jun H. Choi, a hematologist–oncologist at NYU Langone’s Perlmutter Cancer Center, discusses a new treatment for beta thalassemia.
New Biologic Could Target Cancer-Causing Proteins
NYU Langone study describes the development of a biologic drug that targets a mutant cancer protein, HER2, without attacking its counterpart on healthy cells.